
Water, Not Fire: Why We Bet on Aduro's Plastic Recycling Tech
- Marcus Kuhnert
- May 16
- 4 min read
At our May meeting we added Aduro Clean Technologies to the portfolio. This one is a very different animal from Herc — much earlier stage, much higher risk, much bigger potential upside — so it's worth laying out the company and the thesis for anyone who missed the discussion.
What Aduro actually does
Aduro is a Canadian clean tech company (dual-listed on Nasdaq as ADUR and CSE as ACT) that has spent over a decade developing a patented chemical process called Hydrochemolytic Technology, or HCT. In plain English: it's a new way to break down hard-to-recycle plastic waste into valuable chemicals and fuels.
Here's the problem they're attacking: today, most plastic doesn't actually get recycled. Mechanical recycling needs clean, pre-sorted material and degrades quality each cycle. Pyrolysis (the leading chemical recycling method) needs high temps, lots of energy, and clean feedstock. Most of the contaminated, mixed plastic — bags, films, packaging — ends up in landfills or incinerators.
Aduro's HCT uses water as the reaction medium, recycles and reuses that water, and doesn't depend on molecular hydrogen — which requires substantial energy and infrastructure. It runs at 350°C–400°C with low-cost catalysts — meaningfully gentler than competing methods. And critically, it can process polyethylene, polypropylene, AND polystyrene — which together represent roughly 70% of municipal plastic waste.
The same core tech can also upgrade heavy bitumen and convert renewable oils to green fuels. Combined TAM across all three verticals is estimated at over $200B by 2030.
Where they are right now
This is the part that made me comfortable pulling the trigger. Aduro isn't a slide deck — they've actually been hitting milestones:
• Pilot plant operational. As of early 2026, Aduro's Next Generation Process Pilot Plant in London, Ontario is operational, running continuously at 10 kilograms per hour in an industrial configuration. Commissioning completed and operating campaigns began in February 2026.
• FOAK industrial site selected. In January 2026, Aduro selected Chemelot Industrial Park in the Netherlands for its First-of-a-Kind industrial plant, planned at ~10,000 tonnes per year with space for phased expansion. Chemelot is a major European petrochemical hub with shared utilities and proximity to steam crackers — ideal location.
• Permitting underway. Aduro awarded a contract to Ebert HERA to lead permitting for the FOAK facility at Chemelot.
• First offtake commitment. Signed a non-binding LOI on March 12, 2026 with a leading commodities trading company including a committed purchase of the initial production parcel from the FOAK plant.
• Licensing MOU with a major EPC. Signed an MOU on March 19, 2026 to jointly develop a commercial licence package for HCT with a leading global EPC company — this is the path to scaling beyond their own plants.
• Big-name validation. Shell affirmed that the technology works, has potential commercial viability, and that HCT delivered 80% yield. They've also worked with TotalEnergies and have an active partnership with ECOCE in Mexico for flexible packaging.
The thesis (why we bought)
1. The regulatory tailwind is real and structural. The EU's Packaging and Packaging Waste Regulation (PPWR) is forcing minimum recycled content in packaging. Without scalable chemical recycling, those mandates can't be hit. Aduro is positioning right at that bottleneck — and they joined Chemical Recycling Europe in March specifically to engage on the mass balance and certification frameworks being written now.
2. The de-risking arc is moving. Lab → pilot → FOAK → licensing. They've executed the first two steps and the third is funded and underway. Each milestone removes a category of risk and unlocks a step-change in valuation if hit.
3. Asset-light licensing model. Aduro doesn't have to build a hundred plants — they license the technology to industrial partners. If HCT works at FOAK scale, the EPC partnership is the leverage point that turns this into a royalty-style business.
4. Cash to execute. Cash rose to CAD $39.4M from CAD $6.96M after a U.S. offering. That's not infinite, but it's enough to keep the pilot running and advance FOAK engineering.
5. Optionality. Plastic recycling is the lead use case, but the same tech applies to bitumen and renewable oils. Any one of those becoming meaningful is a separate shot on goal.
The risks we acknowledged
This is the highest-risk name we own. Let's be honest about it:
• No real revenue. Q3 FY2026 revenue was nil versus CAD $63,399 prior year, and YTD loss from operations widened to CAD $14.42M. They are burning cash and will need more capital before FOAK generates anything.
• FOAK is years away. Aduro expects construction to be completed in the second half of 2027. Then commissioning, then production. We're sizing for patience.
• Execution risk at scale-up. Tech that works at 10 kg/hr doesn't always work at 10,000 tonnes/year. First-of-a-kind plants miss budget and timeline as a rule, not an exception.
• Dilution risk. Pre-revenue companies fund themselves by issuing shares. They've already done multiple offerings, including an over-allotment closing in January 2026 for ~$3M additional. Expect more.
• Non-binding agreements. The offtake LOI and licensing MOU are great signals but explicitly non-binding. Until they convert, they're just intent.
Bottom line
We bought Aduro as a small, speculative position — explicitly a venture-style bet, sized accordingly. The thesis is that HCT is a genuinely differentiated chemical recycling platform attacking a multi-billion-dollar problem at the exact moment EU regulation is forcing the industry to find a solution. If they hit FOAK commissioning and convert the LOI and MOU into binding deals, the re-rating potential is significant. If they stumble, this could be a zero.
Catalysts to watch from here: pilot plant operating data, FOAK permitting progress at Chemelot, conversion of the offtake LOI and EPC licensing MOU into binding agreements, and the inevitable next capital raise.
This is the kind of name where position sizing matters more than being right. We sized it small for a reason.
Not investment advice — just our club's read on the name.




Comments